Ann Lacasce

Ann Lacasce

UNVERIFIED PROFILE

Are you Ann Lacasce?   Register this Author

Register author
Ann Lacasce

Ann Lacasce

Publications by authors named "Ann Lacasce"

Are you Ann Lacasce?   Register this Author

99Publications

3194Reads

38Profile Views

Treating Hodgkin lymphoma in the new millennium: Relapsed and refractory disease.

Authors:
Ann S LaCasce

Hematol Oncol 2019 Jun;37 Suppl 1:87-91

Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2589DOI Listing
June 2019

Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition.

JAAD Case Rep 2019 May 20;5(5):401-405. Epub 2019 Apr 20.

Department of Dermatology, The Center for Cutaneous Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdcr.2018.03.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479163PMC
May 2019

Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders.

Front Oncol 2019 7;9:109. Epub 2019 Mar 7.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2019.00109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416204PMC
March 2019

Current considerations in AYA Hodgkin lymphoma.

Br J Haematol 2019 01 20;184(1):72-81. Epub 2018 Nov 20.

Department of Medical Oncology, Dana-Farber Cancer Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15640DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310106PMC
January 2019

Preparing Fellows for Graduation: Perspectives on Career Guidance.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:609-614. Epub 2019 May 17.

5 Louisiana State University, New Orleans, LA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_242603DOI Listing
January 2019

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.

N Engl J Med 2018 Nov;379(18):1711-1721

From Stanford University, Stanford (R.A., T.T., R.M., I.L.W.), City of Hope, Duarte (L.P.), and Forty Seven, Menlo Park (J.L., J.Y.C., J.-P.V., B.A., J.H., R.M., I.L.W., C.H.T., M.P.C.) - all in California; Sarah Cannon Research Institute-Tennessee Oncology, Nashville (I.F.); University of Alabama at Birmingham, Birmingham (A.F.); Washington University in St. Louis, St. Louis (N.L.B.); Levine Cancer Institute-Atrium Health, Charlotte, NC (N.G.); University of Chicago, Chicago (J.K., S.M.S.); National Cancer Institute, Rockville, MD (M.R.); Dana-Farber Cancer Institute, Boston (A.L.); and University of Oxford, Oxford, United Kingdom (G.P.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1807315DOI Listing
November 2018

Reply to H.J.A. Adams et al.

J Clin Oncol 2018 Sep 17:JCO1800851. Epub 2018 Sep 17.

Reid W. Merryman and Ann LaCasce, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.18.00851DOI Listing
September 2018

Response-Adapted Therapy in Aggressive Lymphoma: Not Yet Ready for Clinical Care.

J Clin Oncol 2018 07 22;36(20):2009-2011. Epub 2018 May 22.

Reid W. Merryman and Ann S. LaCasce, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.9362DOI Listing
July 2018

Brentuximab Vedotin for Stage III or IV Hodgkin’s Lymphoma.

N Engl J Med 2018 04;378(16):1560

Dana–Farber Cancer Institute, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1802363DOI Listing
April 2018

Pretransplant functional imaging and outcome in pediatric patients with relapsed/refractory Hodgkin lymphoma undergoing autologous transplantation.

Pediatr Blood Cancer 2018 Jan 11;65(1). Epub 2017 Jul 11.

Department of Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26707DOI Listing
January 2018

How to Approach a Patient With Limited Stage Hodgkin Lymphoma Who Remains PET Positive at the End of Chemotherapy: Radiation Therapy?

Clin Lymphoma Myeloma Leuk 2017 11 29;17(11):710-715. Epub 2017 Jun 29.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650173065
Publisher Site
http://dx.doi.org/10.1016/j.clml.2017.06.019DOI Listing
November 2017

Adolescent and young adult lymphoma: collaborative efforts toward optimizing care and improving outcomes.

Blood Adv 2017 Oct 10;1(22):1945-1958. Epub 2017 Oct 10.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2017008748DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728148PMC
October 2017

Case 25-2017.

N Engl J Med 2017 Aug;377(7):677-688

From the Department of Medical Oncology, Dana-Farber Cancer Institute (A.S.L.), the Departments of Radiology (E.J.F.), Medicine (R.H.G.), and Pathology (A.R.S.), Massachusetts General Hospital, and the Departments of Medicine (A.S.L., R.H.G.), Radiology (E.J.F.), and Pathology (A.R.S.), Harvard Medical School - all in Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMcpc1706099DOI Listing
August 2017

Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.

J Clin Oncol 2017 May 9;35(14):1598-1605. Epub 2017 Jan 9.

Christopher J. Gibson, R. Coleman Lindsley, Brenton G. Mar, Jiantao Shi, Ann S. Lacasce, Arnold S. Freedman, David C. Fisher, Eric Jacobsen, Philippe Armand, Edwin P. Alyea, John Koreth, Vincent Ho, Robert J. Soiffer, Joseph H. Antin, Jerome Ritz, Sarah Nikiforow, Franziska Michor, and Donna Neuberg, Dana-Farber Cancer Institute; Jiantao Shi and Franziska Michor, Harvard T.H. Chan School of Public Health; Siddhartha Jaiswal, Elizabeth A. Morgan, and Benjamin L. Ebert, Brigham and Women's Hospital, Boston; Benjamin L. Ebert, Broad Institute, Cambridge, MA; Vatche Tchekmedyian, Memorial Sloan Kettering Cancer Center, New York, NY; Alysia Bosworth, Anita Bansal, and Stephen J. Forman, City of Hope National Medical Center, Duarte, CA; and Liton Francisco, Jianbo He, Ravi Bhatia, and Smita Bhatia, University of Alabama at Birmingham, Birmingham, AL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.6712DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455707PMC
May 2017

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation.

J Clin Oncol 2017 Jan 24;35(1):24-31. Epub 2016 Oct 24.

Alex F. Herrera, Matthew Mei, Lawrence Low, Joo Y. Song, Victoria Bedell, Lithua Budde, Wing C. Chan, Robert Chen, Joyce Murata-Collins, Auayporn P. Nademanee, Raju Pillai, Leslie Popplewell, Tanya Siddiqi, Jasmine Zain, Steven T. Rosen, Larry W. Kwak, Stephen J. Forman, Dennis D. Weisenburger, Young Kim, Amrita Krishnan, Tanya Paris, Tracey Stiller, Joycelynne M. Palmer, City of Hope National Medical Center, Duarte, CA; Haesook T. Kim, Jennifer R. Brown, Matthew S. Davids, Arnold S. Freedman, David C. Fisher, Eric D. Jacobsen, Caron A. Jacobson, Ann S. LaCasce, David M. Weinstock, Scott J. Rodig, Philippe Armand, Dana-Farber Cancer Institute; Gabriel K. Griffin, Reid W. Merryman, Christine Pak, Heather Sun, Brigham and Women's Hospital; German A. Pihan, Beth Israel Deaconess Medical Center; and Aliyah R. Sohani, Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.2740DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455688PMC
January 2017

High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex.

J Natl Compr Canc Netw 2016 10;14(10):1274-1281

From Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Biostatistics and Data Coordinating Center, City of Hope National Medical Center, Duarte, California; Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas; Hematology and Stem Cell Transplantation, City of Hope National Medical Center, Duarte, California; University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan; Departments of Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, New York; Fox Chase Cancer Center, Philadelphia, Pennsylvania; Medicine/Lymphoma, Memorial Sloan Kettering Cancer Center, New York, New York; and James P. Wilmot Cancer Center, University of Rochester, Rochester, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531178PMC
http://dx.doi.org/10.6004/jnccn.2016.0136DOI Listing
October 2016

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.

J Natl Compr Canc Netw 2016 09;14(9):1067-79

From Memorial Sloan Kettering Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; The University of Texas MD Anderson Cancer Center; Massachusetts General Hospital Cancer Center; Stanford Cancer Institute; UCSF Helen Diller Family Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Fox Chase Cancer Center; Huntsman Cancer Institute at the University of Utah; Mayo Clinic Cancer Center; Roswell Park Cancer Institute; University of Michigan Comprehensive Cancer Center; Duke Cancer Institute; Consultant; Dana-Farber/Brigham and Women's Cancer Center; Fred & Pamela Buffett Cancer Center; City of Hope Comprehensive Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; University of Colorado Cancer Center; Vanderbilt-Ingram Cancer Center; UC San Diego Moores Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Alabama at Birmingham Comprehensive Cancer Center; Moffitt Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; St. Jude Children's Research Hospital/University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0117DOI Listing
September 2016

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Authors:
Elizabeth C Townsend Mark A Murakami Alexandra Christodoulou Amanda L Christie Johannes Köster Tiffany A DeSouza Elizabeth A Morgan Scott P Kallgren Huiyun Liu Shuo-Chieh Wu Olivia Plana Joan Montero Kristen E Stevenson Prakash Rao Raga Vadhi Michael Andreeff Philippe Armand Karen K Ballen Patrizia Barzaghi-Rinaudo Sarah Cahill Rachael A Clark Vesselina G Cooke Matthew S Davids Daniel J DeAngelo David M Dorfman Hilary Eaton Benjamin L Ebert Julia Etchin Brant Firestone David C Fisher Arnold S Freedman Ilene A Galinsky Hui Gao Jacqueline S Garcia Francine Garnache-Ottou Timothy A Graubert Alejandro Gutierrez Ensar Halilovic Marian H Harris Zachary T Herbert Steven M Horwitz Giorgio Inghirami Andrew M Intlekofer Moriko Ito Shai Izraeli Eric D Jacobsen Caron A Jacobson Sébastien Jeay Irmela Jeremias Michelle A Kelliher Raphael Koch Marina Konopleva Nadja Kopp Steven M Kornblau Andrew L Kung Thomas S Kupper Nicole R LeBoeuf Ann S LaCasce Emma Lees Loretta S Li A Thomas Look Masato Murakami Markus Muschen Donna Neuberg Samuel Y Ng Oreofe O Odejide Stuart H Orkin Rachel R Paquette Andrew E Place Justine E Roderick Jeremy A Ryan Stephen E Sallan Brent Shoji Lewis B Silverman Robert J Soiffer David P Steensma Kimberly Stegmaier Richard M Stone Jerome Tamburini Aaron R Thorner Paul van Hummelen Martha Wadleigh Marion Wiesmann Andrew P Weng Jens U Wuerthner David A Williams Bruce M Wollison Andrew A Lane Anthony Letai Monica M Bertagnolli Jerome Ritz Myles Brown Henry Long Jon C Aster Margaret A Shipp James D Griffin David M Weinstock

Cancer Cell 2016 07 11;30(1):183. Epub 2016 Jul 11.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2016.06.008DOI Listing
July 2016

US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.

J Clin Oncol 2016 06 11;34(17):2020-7. Epub 2016 Apr 11.

Oliver W. Press, Fred Hutchinson Cancer Research Center, and the University of Washington; Hongli Li and Michael LeBlanc, Fred Hutchinson Cancer Research Center, Seattle, WA; Heiko Schöder, David J. Straus, Craig H. Moskowitz, and Ariela Noy, Memorial Sloan Kettering Cancer Center; John P. Leonard, Weill Cornell Medical College and New York Presbyterian Hospital, New York City; Paul M. Barr and Jonathan W. Friedberg, University of Rochester Medical Center, Rochester, NY; Lisa M. Rimsza, University of Arizona, Tucson, AZ; Nancy L. Bartlett and Brad S. Kahl, Washington University School of Medicine, St. Louis, MO; Andrew M. Evens, Tufts Medical Center; Ann S. LaCasce, Dana-Farber Cancer Institute, Boston, MA; Erik S. Mittra, Stanford University Medical Center, Stanford, CA; John W. Sweetenham, Huntsman Cancer Hospital, Salt Lake City, UT; Michelle A. Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Michael V. Knopp, The Ohio State University, Columbus; Eric D. Hsi, Cleveland Clinic Foundation; James R. Cook, Cleveland Clinic, Cleveland, OH; Mary Jo Lechowicz, Winship Cancer Institute of Emory University, Atlanta, GA; Randy D. Gascoyne, British Columbia Cancer Agency, Vancouver, BC; Bruce D. Cheson, Georgetown University Hospital, Washington DC; and Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.1119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966513PMC
June 2016

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Authors:
Elizabeth C Townsend Mark A Murakami Alexandra Christodoulou Amanda L Christie Johannes Köster Tiffany A DeSouza Elizabeth A Morgan Scott P Kallgren Huiyun Liu Shuo-Chieh Wu Olivia Plana Joan Montero Kristen E Stevenson Prakash Rao Raga Vadhi Michael Andreeff Philippe Armand Karen K Ballen Patrizia Barzaghi-Rinaudo Sarah Cahill Rachael A Clark Vesselina G Cooke Matthew S Davids Daniel J DeAngelo David M Dorfman Hilary Eaton Benjamin L Ebert Julia Etchin Brant Firestone David C Fisher Arnold S Freedman Ilene A Galinsky Hui Gao Jacqueline S Garcia Francine Garnache-Ottou Timothy A Graubert Alejandro Gutierrez Ensar Halilovic Marian H Harris Zachary T Herbert Steven M Horwitz Giorgio Inghirami Andrew M Intlekofer Moriko Ito Shai Izraeli Eric D Jacobsen Caron A Jacobson Sébastien Jeay Irmela Jeremias Michelle A Kelliher Raphael Koch Marina Konopleva Nadja Kopp Steven M Kornblau Andrew L Kung Thomas S Kupper Nicole R LeBoeuf Ann S LaCasce Emma Lees Loretta S Li A Thomas Look Masato Murakami Markus Muschen Donna Neuberg Samuel Y Ng Oreofe O Odejide Stuart H Orkin Rachel R Paquette Andrew E Place Justine E Roderick Jeremy A Ryan Stephen E Sallan Brent Shoji Lewis B Silverman Robert J Soiffer David P Steensma Kimberly Stegmaier Richard M Stone Jerome Tamburini Aaron R Thorner Paul van Hummelen Martha Wadleigh Marion Wiesmann Andrew P Weng Jens U Wuerthner David A Williams Bruce M Wollison Andrew A Lane Anthony Letai Monica M Bertagnolli Jerome Ritz Myles Brown Henry Long Jon C Aster Margaret A Shipp James D Griffin David M Weinstock

Cancer Cell 2016 04;29(4):574-586

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2016.03.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5177991PMC
April 2016

Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability.

J Natl Cancer Inst 2016 Jan 5;108(1). Epub 2015 Oct 5.

Division of Population Sciences (OOO, AMC, GAA), Center for Lymphoma (OOO, ASL), and Center for Leukemia (GAA), Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Ontario Institute for Cancer Research, Toronto, Canada (CCE).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv280DOI Listing
January 2016

Role of 2-Deoxy-2-[18F]-fluoro-d-glucose-PET/Computed Tomography in Lymphoma.

PET Clin 2015 Apr 24;10(2):207-25. Epub 2015 Jan 24.

Department of Imaging, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2014.12.005DOI Listing
April 2015

Limited stage diffuse large B-cell lymphoma: comparative effectiveness of treatment strategies in a large cohort of elderly patients.

Leuk Lymphoma 2015 Mar 6;56(3):716-24. Epub 2014 Aug 6.

Division of Population Sciences, Dana-Farber Cancer Institute , Boston, MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.930853DOI Listing
March 2015

The epidemiology of herpes zoster and its complications in Medicare cancer patients.

BMC Infect Dis 2015 Feb 27;15:106. Epub 2015 Feb 27.

Analysis Group, Inc., 111 Huntington Ave., Tenth Floor, Boston, MA, 02199, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12879-015-0810-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352235PMC
February 2015

How I treat Burkitt lymphoma in adults.

Blood 2014 Nov 25;124(19):2913-20. Epub 2014 Sep 25.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-06-538504DOI Listing
November 2014

Targeting Epstein-Barr virus-associated lymphomas.

J Clin Oncol 2014 Mar 3;32(8):830-2. Epub 2014 Feb 3.

Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.53.2994
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.53.2994DOI Listing
March 2014

Improving the quality of bone marrow assessment: Impact of operator techniques and use of a specimen preparation checklist.

Cancer 2013 Oct 6;119(19):3472-8. Epub 2013 Aug 6.

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28249DOI Listing
October 2013

Biology of double-hit B-cell lymphomas.

Curr Opin Hematol 2012 Jul;19(4):299-304

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0b013e328353bbbdDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389520PMC
July 2012

Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy.

Int J Radiat Oncol Biol Phys 2012 May 20;83(1):277-83. Epub 2011 Oct 20.

Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2011.05.078DOI Listing
May 2012

Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia.

Clin Cancer Res 2011 May 14;17(9):2977-86. Epub 2011 Mar 14.

Massachusetts General Hospital Cancer Center, Medical Oncology and Department of Biostatistics, Dana-Farber Cancer Institute, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2879DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108904PMC
May 2011

Long-term complications of lymphoma and its treatment.

J Clin Oncol 2011 May 11;29(14):1885-92. Epub 2011 Apr 11.

Brigham and Women’s Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2011/04/11/JCO.2010.32
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2010.32.8427
Publisher Site
http://dx.doi.org/10.1200/JCO.2010.32.8427DOI Listing
May 2011

Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma.

J Clin Oncol 2011 Apr 18;29(11):e297-300. Epub 2011 Jan 18.

Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.33.2320DOI Listing
April 2011

Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.

J Clin Oncol 2011 Feb 28;29(6):690-7. Epub 2010 Dec 28.

Center for Lymphoma and Myeloma, Weill Cornell Medical College, 525 East 68th St, Starr 340, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.31.1142DOI Listing
February 2011

Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation.

Blood 2011 Jan 21;117(2):412-8. Epub 2010 Sep 21.

Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-06-291328DOI Listing
January 2011

Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma.

Cancer 2010 Dec 27;116(23):5432-9. Epub 2010 Jul 27.

Center for Lymphoma and Myeloma, Weill Cornell Medical College and New York Presbyterian Hospital, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25509DOI Listing
December 2010

Lymphoma: risk and response after solid organ transplant.

Oncology (Williston Park) 2010 Sep;24(10):936-44

Division of Oncology, Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
September 2010

Cardiac presentation of anaplastic large-cell lymphoma.

J Clin Oncol 2010 Jul 1;28(19):e314-6. Epub 2010 Jun 1.

Brigham and Women's Hospital; Dana Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.26.7583DOI Listing
July 2010